• Home
  • Publications
  • Podcasts
  • Media Engagement
  • Projects
    • Patient Protection Laws
    • 340B Program
  • FAQ
  • collaborators
  • About
  • More
    • Home
    • Publications
    • Podcasts
    • Media Engagement
    • Projects
      • Patient Protection Laws
      • 340B Program
    • FAQ
    • collaborators
    • About
  • Home
  • Publications
  • Podcasts
  • Media Engagement
  • Projects
    • Patient Protection Laws
    • 340B Program
  • FAQ
  • collaborators
  • About

Media Engagement

  • Pharmacy Times, 3/20/2025, Concerns Surrounding Compounded GLP-1s Mount As Shortages of Tirzepatide, Semaglutide End, https://cutt.ly/HroA1YLh 
  • Kentucky Voice, 2/7/2025, 340B legislation in KY with Jim Waters, https://cutt.ly/be52i4uG 
  • Hartford Business, 1/27/2025, Lamont says his budget will raise R&D tax credit to 90%, asks bioscience execs for help with drug prices, https://cutt.ly/Oe40Z6xu 
  • AJMC, 6/19/2024, Part 2: Unlocking the Potential of Biosimilars to Improve Health Equity, https://cutt.ly/ieaoqSDy 
  • AJMC, 5/7/2024, Part 1: Unlocking the Potential of Biosimilars to Improve Health Equity, https://cutt.ly/Terteg6e
  • WSJ, 4/29/2024, Coming to a CVS Near You: A Store Brand Monoclonal Antibody https://cutt.ly/geqjTaoj 
  • The Vicki McKenna Show, 2/7/2024, https://cutt.ly/jwCflXRp 
  • Creaky Joints, 9/8/2023, The Inflation Reduction Act and Drug Price Negotiations: What Chronic Illness Patients Should Know, https://cutt.ly/lwv9tEWj 
  • Yahoo News, 8/24/2023, CVS launches unit to market and co-produce biosimilar medicines, https://cutt.ly/7wjxaZIB
  • First Word, 7/30/2023, The ICER Effect: Payer Perspectives, https://cutt.ly/pwpoIJk5 
  • Reuters, 7/10/2023, Cigna to add three Humira biosimilars to drug reimbursement list, https://cutt.ly/twi0bewm 
  • Reuters, 6/30/2023, Analysis: New Humira rivals likely to hit US market with small discounts in July, https://cutt.ly/5wu0yqpE 
  • Rheumatologist, 4/7/2023, Mark Cuban: Mixing Up the Pharmaceutical Landscape, https://cutt.ly/D74VIWw 
  • Morning Brew, 4/4/2023, Drugs left off PBM lists can lead to worse patient outcomes, higher costs, https://cutt.ly/k7cwqIX 
  • Health Central, 4/3/2023, Asthma Meds, Insurers, and the Practice of Non-Medical Drug Switching, https://cutt.ly/Y7aRBIk 
  • Employee Benefit News, 4/3/2023, The insulin cap is great news for patients — but employers may see even higher premiums, https://cutt.ly/x7aRD9l 
  • Medscape, 3/30/2023, Biosimilars and Patients: Discussions Should Address Safety, Cost, and Anxiety About Change, https://cutt.ly/awwDh5aY
  • Pharmacy Practice News, 3/15/2023, New Report: Pharmacists Providing Vax More Often Than MDs, https://cutt.ly/34yvIC0
  • Docwire, 3/10/2023, Report Shows Increase in Pharmacy-Based Vaccinations in U.S. Across Multiple Vaccines, https://cutt.ly/n4jdotb 
  • Managed Healthcare Executive, 3/8/2023, The List of PBM Formulary Exclusions Got Longer in 2023, https://cutt.ly/r4js4eP 
  • Pluribus News, 2/15/2023, As Covid emergency expires, states want to let pharmacists give vaccines, https://cutt.ly/f3JcMj9 
  • Creaky Joints, 2/15/2023, More Biosimilars Are Coming, But Don’t Expect Instant Savings, https://cutt.ly/N3DQL4N 
  • Employee Benefits News, 2/9/2023, The end of the PREP Act will impact access to vaccinations, https://cutt.ly/z3kpr71 
  • Reuters,1/31/2023, AbbVie's Humira gets a U.S. rival, but costs could stay high, https://cutt.ly/Q9G10zY 
  • Drug Channels, 1/10/2023, The Big Three PBMs’ 2023 Formulary Exclusions: Observations on Insulin, Humira, and Biosimilars, https://cutt.ly/b4gIlQN
  • Inside Health Policy, 12/13/2022, CMS Rejects Call to Ban Copay Accumulators In Draft 2024 Exchange Rule, https://cutt.ly/h2N3o7d 
  • USA Today, 11/3/2022, Is prescription copay assistance contributing to rising drug prices? Why buyers should beware. https://cutt.ly/X2N3ttj
  • USA Today, 11/1/2022, How do patient assistance programs work? The pros and cons of prescription coupons and more. https://cutt.ly/t2N3qHM 
  • Creaky Joints, 8/31/2022, Tuberculosis Vaccine Might Offer Some Protection Against COVID, https://cutt.ly/K2N97YI
  • Creaky Joints, 8/8/2022, Are Pharmacists the Key to Increased Vaccination Rates? https://cutt.ly/w2N99Av
  • Contagion Live, 8/4/2022, In Low-Income Communities, Pharmacists Can Play a Critical Role in Vaccine Access, https://cutt.ly/L2N9N3s
  • Healio, 7/20/2022, Nearly half of formulary exclusions offer ’questionable‘ clinical, economic benefit, https://cutt.ly/F2N9ZtO 
  • Creaky Joints, 7/8/2022, Warning: Your Health Insurance Might Not Cover the Meds You Need Most, https://cutt.ly/42N9Hgp 
  • Pharmacy Today, 7/7/2022, Pharmacists’ expanded scope of practice here to stay?
  • American Journal of Managed Care, 6/28/2022, Mental Health, Immunizations, Sleep Focus of Barriers in Prevention and High-Value Care, https://cutt.ly/Y2N9Pp5 
  • Infectious Disease Advisor, 5/27/2022, The Case for Expanding Pharmacists’ Authority to Administer Vaccines, https://cutt.ly/c2N9U91 
  • Pharmacy Today, 3/1/2022, Most physicians unable to estimate patients’ out-of-pocket costs: How pharmacists can help
  • The Center for Biosimilars, 1/12/2022, Biosimilar Progress and Education in the United States, https://cutt.ly/XIpqoxL 
  • accessWDUN.com, 12/31/2021, Covid-19 vaccines and antiviral treatments, https://cutt.ly/w2N9R8b 
  • Pharmacy Today, 10/01/2021, Walmart–Novo Nordisk insulin offers deep discounts to select few
  • Ohio Capital Journal, 7/22/2021, Chucking insurance, https://cutt.ly/f2N9Q94 
  • Pharmacy Today, 5/12/2021, Cash-based pharmacies deliver transparency, savings
  • Biosimilars Review and Report, 4/6/2021, Biosimilars, Employers, Medicaid, and Rebates, https://cutt.ly/y2N9kzv 
  • The Hill, 3/6/2019, Drug rebates not benefiting sicker patients, https://cutt.ly/U2N9aeW 
  • Politico, 5/9/2018, A Better Prescription: Biosimilars and a Pathway to Patient Choice, https://cutt.ly/Z2N2MXZ 
  • Managed Healthcare Executive, 1/28/2018, Pfizer VP Robert Popovian Talks Value-Based Reimbursement, https://cutt.ly/l2N24pD 
  • Public Affairs Council, 11/13/2017, Do Big Donors Compromise Think Tanks? https://cutt.ly/M2N2Xso 
  • Pink Sheet, 8/27/2014, Biomedical Reform Legislation May Be Piecemeal But Holistic, https://cutt.ly/v2N2K7V 
  • Bloomberg News, 3/4/2011, Pfizer-Backed Bills Threaten Medicaid Generic Savings: Insight
  • Pink Sheet, 2/21/2011, Lobbying Around State eRx Legislation Pits Payers Against Manufacturers
  • The Grand Rapids Press, 3/9/2008, Health plans push harder for use of generic drugs, not as 'equivalents' but as 'alternatives', https://cutt.ly/E2N2bSK 
  • USA Today, 12/9/2004,,Web site compares drugs for 'best buys', https://cutt.ly/w2N2xV9 
  • Los Angeles Times, 9/10/1995, Drug Use Weakened Allegations of Abuse, https://cutt.ly/B2N2zkA 

Conquest Advisors

Copyright © 2025 Conquest Advisors - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept